NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $144,000 | -28.7% | 1,895 | -20.9% | 0.04% | -25.9% |
| Q2 2022 | $202,000 | +225.8% | 2,395 | +237.8% | 0.05% | +260.0% |
| Q1 2022 | $62,000 | -19.5% | 709 | -19.9% | 0.02% | -16.7% |
| Q4 2021 | $77,000 | +6.9% | 885 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $72,000 | -10.0% | 885 | 0.0% | 0.02% | -10.0% |
| Q2 2021 | $80,000 | +5.3% | 885 | 0.0% | 0.02% | -4.8% |
| Q1 2021 | $76,000 | -9.5% | 885 | 0.0% | 0.02% | -19.2% |
| Q4 2020 | $84,000 | +10.5% | 885 | 0.0% | 0.03% | -3.7% |
| Q3 2020 | $76,000 | -1.3% | 885 | 0.0% | 0.03% | -6.9% |
| Q2 2020 | $77,000 | +8.5% | 885 | 0.0% | 0.03% | -14.7% |
| Q1 2020 | $71,000 | +6.0% | 885 | +24.8% | 0.03% | +54.5% |
| Q4 2019 | $67,000 | +9.8% | 709 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $61,000 | -6.2% | 709 | 0.0% | 0.02% | -8.3% |
| Q2 2019 | $65,000 | – | 709 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |